Examining Increases in Aluminum Adjuvant Exposure

Though aluminum is scientifically proven to be detrimental to human health, aluminum’s toxicity has largely been understated or outright ignored, even by agencies tasked with protecting the public’s health. These organizations, like the CDC and FDA, are well-aware of research published on the toxic properties of aluminum; yet, aluminum adjuvants are not only present in many vaccines, but are increasing in concentration.

The latest release of the Gardasil HPV vaccine, Gardasil 9, is one example of increasing quantities of aluminum adjuvants. Gardasil 9, which has been engineered to protect against 9 different types of HPV, now contains more than twice the amount of aluminum adjuvant as Gardasil’s original version. Even Gardasil manufacturer Merck’s own study of its original version revealed alarming statistics about serious adverse effects of the vaccine, including disabilities and precancerous lesions, while independent research has identified more than 22,000 adverse effects associated with the Gardasil vaccine. Gardasil 9 contains 500 mg of aluminum adjuvant, while Gardasil contains just 225 mg; considering Gardasil 9 is administered in 3 doses over the course of 3 years, this means that recipients will intramuscularly receive 1500 mg of aluminum throughout their Gardasil 9 administration.

Gardasil 9 was also approved by the FDA without a review from the Vaccines and Related Biological Products Advisory Committee, a committee specifically tasked with assessing potential risk factors of vaccines that are up for FDA approval. In its letter of explanation, the FDA stated that Gardasil 9 did not present the type of controversy or concern that would merit a review from the VRBPAC. However, it’s only up to the VRBPAC itself to determine if any concerns exist. Forbes has already reported that a study of Gardasil 9 involving 13,000 recipients resulted in 305 reports of serious adverse effects.

Research supported by the Children’s Safety Medical Research Institute has also revealed that the Gardasil vaccine is 2.5 times more likely to cause a serious adverse effect than cervical cancer, the threat Gardasil is intended to protect against.

Aluminum adjuvants remain present in a wide range of routinely administered vaccines, including tetanus, diphtheria, hepatitis, and pertussis vaccines; because no official threshold has been established for safe quantities of aluminum exposure, no plans are in the works to reduce these current concentrations of aluminum adjuvants.  As researcher Christopher Exley points out in his paper, “Human Exposure to Aluminum,” in 1950 Americans were exposed to approximately 1 mg of aluminum per day. By 2050, it’s projected that our level of daily exposure will increase to 100 mg.

Direct links have also recently been demonstrated between aluminum and Alzheimer’s disease, a neurological disease which, like autism, has been rapidly increasing in recent decades. In 2010 there were 500,000 new cases of Alzheimer’s, and this number is increasing each year. By 2050, it’s expected there will be 1 million new cases of Alzheimer’s each year. While some cases of Alzheimer’s result from genetic dispositions, its rapidly increasing rates are best explained by exposures to toxic environmental elements, like aluminum, which we are exposed to in increasing amounts and via more diverse avenues.

Unfortunately, there’s little question that our exposure to aluminum is increasing, and that little is being done to reduce it. It seems it will be up to researchers and a conscientious public to begin to change views about this highly toxic element.



The Mission & Work of the Dwoskin Family Foundation

Albert and Lisa Claire Dwoskin are passionate about children’s health. In 2001, they decided it was time to create a foundation of their own through which they could give back some of their good fortune and use their donations to directly support underfunded areas of children’s health research. The Dwoskin Family Foundation was created, a 501(c)3 non-profit charitable foundation.

Claire Dwoskin went to work immediately. She and other child health advocates and scientists began identifying neglected health threats and areas of research that were not receiving adequate attention and funding. In particular, she was alarmed by the research showing that vaccines may have significant health risks for children, and at the high number of chronically ill and disabled children in clinics and waiting rooms. Although vaccines are believed to prevent a number of infectious diseases, some researchers have found evidence that these same vaccines can also cause life-altering medical conditions.


Although high quality vaccine safety research was limited, Claire Dwoskin felt it was worth exploring. This seemed especially prudent because the belief that vaccines are safe and effective had become dogma in the medical establishment. Even scientists and doctors were unaware that vaccines were tested against groups receiving other vaccines or aluminum containing placebos, instead of true placebos. Many believed the vaccine schedule in its entirety had been tested for safety, considering they have cumulative and synergistic effects. Something had to be driving up the incidence of chronic illness and disability in children that adults were not exposed to, as there were few adults similarly affected.

Doctors routinely issue scores of vaccines to children in developed nations, and international organizations are working tirelessly to bring these vaccines to developing nations as well. If the very tools that are becoming standard worldwide for protecting children are also causing disease, she felt people had a right to accurate information about how vaccines affect overall health.

This research helped set the direction for the Dwoskin Family Foundation overall. Research into vaccine safety has become a major priority of the Foundation, and it has expressed that mission by giving substantial support to the Children’s Medical Safety Research Institute. CMSRI is dedicated to carrying out research on the biological and genetic effects of vaccines and making data from its findings available in a way that can influence public health policy.

In particular, CMSRI has focused on the possibility that vaccines have effects on brain health and may be linked to autism in children. Similarly, CMSRI’s research has examined whether vaccines, which stimulate the immune system, may be triggers or causes for auto-immune disorders, some of which are on the rise. Finally, a great deal of CMSRI’s work has been focused at identifying potential toxicity of ingredients in common vaccines.

The Dwoskin Family Foundation continues to support CMSRI and other related children’s safety research causes, in the hopes that parents will have a more complete understanding of the full effects of the pediatric vaccine schedule—and that where needed, best medical practices and vaccine recommendations can be adjusted. This is work that Claire Dwoskin, her husband Albert, and everyone involved in the Foundation and CMSRI believe can improve health and better the world.